OPIANT PHARMACEUTICALS, INC. 4 SEC Filings

Filed On	Filing
03 Mar 2023	Form 4: Silver Gabrielle Alison, Director Returned 23,343 shares to the issuer ($467K) · Disposed of 7,500 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 2,500 Common Stock (Disposition to Issuer)
03 Mar 2023	Form 4: Collard Craig A, Director Returned 55,822 shares to the issuer ($1.12M) · Disposed of 7,500 Common Stock (Disposition to Issuer) · Disposed of 5,000 Stock Option (right to buy) (Disposition to Issuer)
03 Mar 2023	Form 4: Ruth Matthew R., Chief Commercial Officer Returned 31,916 shares to the issuer ($638K) · Received 2,000 shares as a grant or award · Disposed of 50,000 Stock Option (right to buy) (Disposition to Issuer)
03 Mar 2023	Form 4: Daly Richard J, Director Returned 7,800 shares to the issuer ($156K) · Disposed of 10,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 2,500 Common Stock (Disposition to Issuer)
03 Mar 2023	Form 4: Crystal Roger, Director Returned 82,006 shares to the issuer ($1.64M) · Returned 5,100 shares to the issuer ($102K) · Received 6,667 shares as a grant or award · 3 more
03 Mar 2023	Form 4: Ellison Mark Jason Heath, Chief Development Officer Returned 30,431 shares to the issuer ($609K) · Received 2,000 shares as a grant or award · Disposed of 15,450 Common Stock (Disposition to Issuer) · 1 more
03 Mar 2023	Form 4: Skolnick Phil, Chief Scientific Officer Returned 23,548 shares to the issuer ($471K) · Received 2,000 shares as a grant or award · Disposed of 63,950 Stock Option (right to buy) (Disposition to Issuer) · 1 more
03 Mar 2023	Form 4: Sinclair Michael, Director Returned 27,450 shares to the issuer ($549K) · Returned 62,720 shares to the issuer ($1.25M) · Disposed of 425,000 Options (Disposition to Issuer)
03 Mar 2023	Form 4: MacDougall Ann L., Director Returned 28,179 shares to the issuer ($564K) · Disposed of 7,500 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 2,500 Common Stock (Disposition to Issuer)
03 Mar 2023	Form 4: Lorianne Masuoka K., Director Returned 4,000 shares to the issuer ($80K) · Disposed of 5,000 Stock Option (right to buy) (Grant/Award Acquisition)
03 Mar 2023	Form 4: Gorman Brian, General Counsel Returned 33,990 shares to the issuer ($680K) · Received 2,000 shares as a grant or award · Disposed of 47,250 Stock Option (right to buy) (Disposition to Issuer)
03 Mar 2023	Form 4: Thomas Thomas T., Director Returned 12,375 shares to the issuer ($248K) · Disposed of 7,500 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 2,500 Common Stock (Disposition to Issuer)
03 Mar 2023	Form 4: O'Toole David D, Chief Financial Officer Returned 36,248 shares to the issuer ($725K) · Received 2,000 shares as a grant or award · Disposed of 43,750 Stock Option (right to buy) (Disposition to Issuer) · 1 more
31 Jan 2023	Form 4: Crystal Roger, Director Sold 1,358 shares ($27.5K)
31 Jan 2023	Form 4: Ellison Mark Jason Heath, Chief Development Officer Sold 610 shares ($12.4K)
31 Jan 2023	Form 4: Gorman Brian, General Counsel Sold 444 shares ($9K)
31 Jan 2023	Form 4: Skolnick Phil, Chief Scientific Officer Sold 480 shares ($9.72K)
31 Jan 2023	Form 4: O'Toole David D, Chief Financial Officer Sold 541 shares ($11K)
09 Jan 2023	Form 4: O'Toole David D, Chief Financial Officer Sold 415 shares ($8.38K)
09 Jan 2023	Form 4: Ellison Mark Jason Heath, Chief Development Officer Sold 469 shares ($9.47K)

Comments